Skip to main content

Symposium in Barcelona on future therapies in diabetes

Images

Participants

Contact

Image
Press & Communications Section Head
Tel.+34 93 40 37255

Several media, including Canal Diabetes, has dedicated an article to the first joint meeting of the French, Portuguese and Spanish Biochemistry and Molecular Biology Societies (FEBS3+), which will take place in the Palau de Congressos of the Fira de Barcelona from 23 to 26 October. Gathering top scientists, the meeting will be presided by Antonio Zorzano, group leader at IRB Barcelona and coordinator of the Molecular Medicine Programme, as well as professor at the University of Barcelona and CIBER for Diabetes and Associated Metabolic Diseases.

Link to Canal Diabetes

Link to el Economista

Link to Biotech Spain

Link to El Periódico

Link to ConSalud.es

About IRB Barcelona

The Institute for Research in Biomedicine (IRB Barcelona) pursues a society free of disease. To this end, it conducts multidisciplinary research of excellence to cure cancer and other diseases linked to ageing. It establishes technology transfer agreements with the pharmaceutical industry and major hospitals to bring research results closer to society, and organises a range of science outreach activities to engage the public in an open dialogue. IRB Barcelona is an international centre that hosts 400 researchers and more than 30 nationalities. Recognised as a Severo Ochoa Centre of Excellence since 2011, IRB Barcelona is a CERCA centre and member of the Barcelona Institute of Science and Technology (BIST).